Neurotrophic factors and neural grafts: A growing field

Seminars in Neuroscience

Volumn 5, Issue 6, 1993, Pages 431-441

  Barker, Roger A ^a,b   Dunnett, Stephen B ^b   Fawcett, James W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UK   (United Kingdom)

Author keywords

Intracerebral grafts; Neurotrophic factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR; NERVE GROWTH FACTOR; NEUROTROPIC AGENT;

ALZHEIMER DISEASE; ANIMAL MODEL; CELL SURVIVAL; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CHROMAFFIN CELL; EMBRYONAL TISSUE; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NERVE GRAFT; NONHUMAN; PARKINSON DISEASE; RAT; REVIEW;

EID: 0027730561     PISSN: 10445765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-5765(05)80015-6     Document Type: Article

References (114)

1. Forno LS (1990) Pathology of Parkinson’s disease; the importance of the substantia nigra and Lewy bodies, in Parkinson’s disease (Stern G, ed), pp 185-238. Chapman and Hall, London
2. Martin JB, Gusella JF (1986) Huntington’s disease. Pathogenesis and management. New Engl J Med 315:1267-1276
3. Pearson RCA, Powell TPS (1989) The neuroanatomy of Alzheimer’s disease. Rev Neurosci 2:101-121
4. Mitsumoto H, Hanson MR, Chad DA (1988) Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials. Arch Neurol 45:189-202
5. Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971-983
6. Wictorin K (1992) Anatomy and connectivity of intrastriatal striatal transplants. Prog Neurobiol 38:611-639
7. Dunnett SB, Svendsen CN (1993) Huntington’s disease: Animal models and transplantation repair. Curr Opin Neuriobiol, in press
8. Björklund A (1992) Dopaminergic transplants in experimental parkinsonism: Cellular mechanisms of graft induced functional recovery Curr Opin Neurobiol 2:683-689
9. Barde Y-A (1988) What, if anything, is a neurotrophic factor? Trends Neurosci 11:343-346
10. Thoenen H (1991) The changing scene of neurotrophic factors. Trends Neurosci 14:165-170
11. Appel SH (1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism and Alzheimer’s disease. Ann Neurol 10:499-505
12. Clough CG (1991) Parkinson’s disease management. Lancet 337:1324-1327
13. Barker RA, Dunnett SB (1993) The biology and behaviour of intracerebral adrenal transplants in animals and man Rev Neurosci 4:113-146
14. Freed WJ (1991) Substantia nigra grafts and Parkinson’s disease: From animal experiments to human therapeutic trials. Restor Neurol Neurosci 3:109-134
15. Verhofstad AAJ, Coupland RE, Parker TR, Goldstein M (1985) Immunohistochemical and biochemical study on the noradrenaline and adrenaline storing cells of the adrenal medulla of the rat. Cell Tiss Res 242:233-243
16. Müller TH, Unsicker K (1981) High performance liquid chromatography with electrochemical detection as a highly efficient tool for studying catecholaminergic systems I. Quantification of noradrenaline, adrenaline and dopamine in cultured adrenal medullary cells. J Neurosci Methods 4:39-52
17. Freed WJ, Karoum F, Spoor HE, Morihisa JM, Olson L, Wyatt RJ (1983) Catecholamine content of intracerebral adrenal medulla grafts. Brain Res 269:184-189
18. Becker JB, Curran EJ (1992) Adrenal medulla grafts in hemiparkinsonian rats: Mechanisms mediating recovery of function Restor Neurol Neurosci 4:174
19. Madrazo I, Drucker-Colin R, Diaz V, Martinez-Mata J, Torres C, Beccerrill JJ (1987) Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson’s disease. N Engl J Med 316:831-834
20. Goetz CG, Stebbins GT, Klawans HL, Koller WC, Grossman MD, Bakay RAE, Penn RD, United Parkinson Foundation Neural Transplantation Registry (1992) United Parkinson Foundation Neurotransplantation registry on adrenal medullary transplants: Presurgical and 1 and 2 year follow up. Neurology 41:1719-1722
21. Sawle GV, Myers R (1993) The role of positron emission tomography in the assessment of human neurotransplantation. Trends Neurosci 16:172-176
22. Freed WJ, Perlow MJ, Karoum F, Seiger A, Olson L, Hoffer BJ, Wyatt RJ (1980) Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: Long term behavioral, biochemical and histochemical studies. Ann Neurol 8:510-519
23. Bolam JP, Freund TF, Björklund A, Dunnett SB, Smith AD (1987) Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum. Exp Brain Res 68:131-146
24. Freund TF, Bolam JP, Björklund A, Stenevi U, Dunnett SB, Powell JF, Smith AD (1985) Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: A tyrosine hydroxylase immunocytochemical study. J Neurosci 5:603-616
25. Dunnett SB, Björklund A, Stenevi U, Iversen SD (1981) Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res 229:209-217
26. Dunnett SB, Hernandez TD, Summerfield A, Jones GH, Arbuthnott G (1988) Graft derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic tissues. Exp Brain Res 71:411-424
27. Fahn S (1992) Fetal tissue transplants in Parkinson’s disease. N Engl J Med 327:1589-1590
28. Doupe AJ, Landis SC, Patterson PH (1985) Environmental influences in the development of neural crest derivatives: Glucocorticoids, growth factors and chromaffin cell plasticity. J Neurosci 5:2119-2142
29. Doupe AJ, Patterson PH, Landis SC (1985) Small intensely fluorescent cell in culture: Role of glucocorticoids and growth factors in their development and interconversions with other neural crest derivatives. J Neurosci 5:2143-2160
30. Stromberg I, Ebendal T, Seiger A, Olson L (1985) Nerve fibre production by intraocular adrenal medullary grafts: Stimulation by nerve growth factor or by sympathetic denervation of the host iris. Cell Tiss Res 241:241-249
31. Stromberg I, Herrera-Marschitz M, Ungerstedt U, Ebendal T, Olson L (1985) Chronic implants of chromaffin tissue into the dopamine denervated striatum. Effects of NGF on graft survival, fiber outgrowth and rotational behavior. Exp Brain Res 60:335-349
32. Cunningham LA, Hansen JT, Short MP, Bohn MC (1991) The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted to the striatum. Brain Res 561:192-202
33. Doering LC (1992) Peripheral nerve segments promote consistent long-term survival of adrenal medulla transplants in the brain. Exp Neurol 118:253-260
34. Watts RL, Freeman A, Graham S, Bakay RAE (1992) Early experience with intrastriatal adrenal medulla/nerve cografting in Parkinson’s disease. Restor Neurol Neurosci 4:194
35. Olson L, Holier BJ, Backlund EO, Ebendal T, Freeman R, Hamberger B, Hansson P, Lindbloom U, Myerson B, Stromberg I, Sydow O, Seiger A (1992) Intraputamenal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson’s disease. Restor Neurol Neurosci 4:194
36. Barid A (1993) Fibroblast growth factors: What’s in a name? Endocrinol 132:487-488
37. Bean AJ, Eide R, Cao Y, Oellig C, Tamminga C, Goldstein M, Pettersson RF, Hökfelt T (1991) Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey and human. Proc Natl Acad Sei USA 88:10237-10241
38. Tooyama I, Kawamata T, Walker D, Yamada T, Hanai K, Kimura H, Iwane M, Igarashi K, McGeer EG, McGeer PL (1993) Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson’s disease. Neurology 43:372-376
39. Ferrari G, Minozzi M-C, Toffano G, Leon A, Skaper SD (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol 133:140-147
40. Engele J, Bohn MC (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J Neurosci 11:3070-3078
41. Mayer E, Dunnett SB, Fawcett JW (1993) Mitogenic effects of bFGF on embryonic mesencephalic dopaminergic neurones. Dev Brain Res 72:253-258
42. Mayer E, Dunnett SB, Pelliteri R, Fawcett JW (1993) Basic FGF promotes the survival of embryonic mesencephalic dopaminergic neurones. I. Effects in vitro. Neurosci, in press
43. Patel AJ, Kiss J, Gray G (1992) Organisation of septo-hippocampal neurons and their regulation by trophic factors produced by astrocytes, in Neurodegeneration (Hunter AJ, Clark M, eds), pp 59-80. Academic Press, London
44. Lin L-FH, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132
45. Steinbusch HWM, Vermeulen RJ, Tonnaer JADM (1990) Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat caudate-putamen: Preliminary observations. Prog Brain Res 82:81-86
46. Mayer E, Fawcett JW, Dunnett SB (1993) Basic FGF promotes the survival of embryonic ventral mesencephalic dopaminergic neurones. II. Effects on nigral transplants in vivo. Neurosci, in press
47. Date I, Notter MFD, Felten SY, Felten DL (1990) MPTP- treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res 526:156-160
48. Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10:1912-1921
49. + -damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res 599:83-97
50. Meakin SO, Shooter EM (1992) The nerve growth factor family of receptors. Trends Neurosci 15:323-331
51. Gall CM, Gold SJ, Isackson PJ, Seroogy KB (1992) Brain- derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol Cell Neurosci 3:56-63
52. Magal E, Burnham P, Varon S (1991) Effect of CNTF on low affinity NGF receptor expression by cultured neurons from different rat brain regions. J Neurosci Res 30: 560-566
53. Knüsel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, Hefti F (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc Natl Acad Sci USA 88:961-965
54. Beck KD, Kniisel B, Hefti F (1993) The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)- insulin-like growth factor-1 and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neurosci 52:855-866
55. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4- phenylpyridium ion toxicity: Involvement of the glutathione system. J Neurochem 59:99-106
56. Knüsel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, Widner HR, Nikolics K, Hefti F (1992) Brain derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12:4391-4402
57. Sauer H, Fischer W, Nikkhah G, Wiegand SJ, Brundin P, Lindsay RM, Björklund A (1993) Brain derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res, in press
58. Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C (1992) Brain derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 89:11347-11351
59. Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F (1993) Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neurosci 53:639-650
60. Knüsel B, Michel PP, Schwaber JS, Hefti F (1990) Selective and non-selective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and insulin-like growth factors I and II. J Neurosci 10:558-570
61. Brundin P, Isacson O, Björklund A (1985) Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res 331.251-259
62. Pritzel M, Isacson O, Brundin P, Wiklund L, Björklund A (1986) Afferent and efferent connections of striatal grafts implanted into ibotenic acid lesion striatum in adult rats. Exp Brain Res 65:112-126
63. Dunnett SB, Isacson O, Sirinathsinghji DJS, Clarke DJ, Björklund A (1988) Striatal grafts in the ibotenic acid- lesioned neostriatum: Functional studies. Prog Brain Res 78 39-45
64. Matsuda S, Saito H, Nishiyama N (1990) Effect of basic fibroblast growth factors on neurons cultured from various regions of postnatal rat brain. Brain Res 520:310-316
65. Kessler JA (1986) Differential regulation of cholinergic and peptidergic development in the rat striatum in culture. Dev Biol 113-77-89
66. Okazawa H, Murata M, Watanabe M, Kamei M, Kanazawa I (1992) Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS 313:138-142
67. Schumacher JM, Short MP, Hyman BT, Breakefield XO, Isacson O (1991) Intracerebral implantation of nerve growth factor-producing fibroblasts protect striatum against neurotoxic levels of excitatory amino acids. Neurosci 45:561-570
68. Frim DM, Uhler TA, Short MP, Ezzedine D, Klagsbum M, Breakefield XO, Isacson O (1993) Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. Neuro Report 4-367-370
69. Katzman R, Saitoh T (1991) Advances in Alzheimer’s disease. FASEB J 5:278-286
70. Growdon JH (1992) Treatment for Alzheimer’s disease? N Engl J Med 327:1306-1308
71. Dunnett SB, Everitt BJ, Robbins TW (1992) The basal forebrain-cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14:494-501
72. Dunnett SB, Low WC, Iversen SD, Stenevi U, Björklund A (1982) Septal transplants restore maze learning in rats with fimbria-fornix lesions. Brain Res 251:335-348
73. Nilsson OG, Kalen P, Rosengren E, Björklund A (1990) Acetylcholine release from intrahippocampal septal grafts is under control of the host brain. Proc Natl Acad Sci USA 87:2647-2651
74. Dunnett SB (1991) Neural transplants as a treatment for Alzheimer’s disease? Psychol Med 21:825-830
75. Svendsen CN, Kew JNC, Staley K, Sofroniew MV (1993) NGF withdrawal results in the death of developing but not mature septal cholinergic neurons in vitro: Protection by protein synthesis inhibition. J Neurosci, in press
76. Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Björklund A, Gage FH (1986) Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection. Proc Natl Acad Sci USA 83:9231-9235
77. Tuszynski MH, Sang H, Yoshida K, Gage FH (1991) Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann Neurol 30:625-636
78. Fischer W, Wictorin K, Björklund A, Williams LR, Varon S, Gage FH (1987) Amelioration of cholinergic neuron atrophy and spatial memory in aged rat by nerve growth factor. Nature 329:65-68
79. Tuszynski MH, Buzsaki G, Gage FH (1990) Nerve growth factor infusions combined with fetal hippocampal grafts enhance reconstruction of the lesioned septohippocampal projection. Neurosci 36:33-44
80. Gage FH, Chen KS (1992) Neural transplants: Prospects for Alzheimer’s disease Curr Opin Neurol Neurosurg 5:94-99
81. Strada O, Hirsch EC, Javoy-Agid F, Lehericy S, Ruberg M, Hauw J-J, Agid Y (1992) Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer’s Disease? An autoradiographic study in human striatum and basal forebrain J Neurosci 12:4766-4774
82. Phillips HS, Hains JM, Laramee GR, Rosenthal A, Winslow JW (1990) Widespread expression of BDNF but not NT3 by target areas of basal forebram cholinergic neurons. Science 250:290-294
83. Alderson RF, Alterman AL, Barde Y-A, Lindsay RM (1990) Brain derived neurotrophic factor increase survival and differentiated functions of rat septal cholinergic neurons in culture Neuron 5:297-306
84. Thoenen H, Zafra F, Hengerer B, Lindholm D (1991) The synthesis of nerve growth factor and brain derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems. Ann NY Acad Sci 638:86-90
85. Lindefors N, Ernfors P, Falkenberg T, Persson H (1992) Septal cholinergic afferents regulate expression of brain derived neurotrophic factor and β-nerve growth factor mRNA in rat hippocampus. Exp Brain Res 88:78-90
86. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 7-695-702
87. Lapchak PA, Hefti F (1992) BDNF and NGF treatment in lesioned rats: Effects on cholinergic function and weight gain. NeuroReport 3:405-408
88. Widmer HR, Knüsel B, Hefti F (1993) BDNF protection of basal forebrain cholinergic neurons after axotomy: Complete protection of p75 NGFR-positive cells. NeuroReport 4:363-366
89. McNamara JO, Fridovich I (1993) Did radicals strike Lou Gehrig? Nature 362:20-21
90. Cadusseau J, Nothias F, Alanbari A, Peschanski M (1993) Development of motorneurons in spinal transplants. Restor Neurol Neurosci 5:61-63
91. Clowry G, Sieradzan K, Vrbová G (1991) Grafts of embryonic tissue into spinal cord: A possible strategy for treating neuromuscular disorders. Neuromusc Disord 1:87-92
92. Kunkel-Bagden E, Bregman BS (1990) Spinal cord transplants enhance the recovery of locomotor function after spinal cord injury at birth. Exp Brain Res 81:25-34
93. Lowrie MB, Vrbová G (1992) Dependence of postnatal motoneurones on their targets: Review and hypothesis. Trends Neurosci 15:80-84
94. Sieradzan K, Clowry G, Haynes L, Vrbová G (1992) The ability of isolated embryonic motoneurones grafted into rat spinal cord to express cholinergic markers and innervate skeletal muscle. Restor Neurol Neurosci 4:220
95. Nothias F, Horvat JC, Mira JC, Pécot-Dechavassine M, Peschanski M (1990) Double step neural transplants to replace degenerated motoneurons. Prog Brain Res 82:239-246
96. Oppenheim RW (1992) High hopes of a trophic factor. Nature 358:451-452
97. Yan Q, Elliott J, Snider WD (1992) Brain derived neurotrophic factor rescues spinal motor neurons after axotomy-induced cell death. Nature 360:753-755
98. Sendtner M, Holtman B, Kolbeck R, Thoenen H, Barde Y-A (1992) Brain derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360:757-759
99. Arakawa Y, Sendtner M, Thoenen H (1990) Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: Comparison with other neurotrophic factors and cytokines. J Neurosci 10:3507-3515
100. Stöckli KA, Lottspeich F, Sendtner M, Masiakowski P, Carroll P, Götz R, Lindholm D, Thoenen H (1989) Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature 342:920-923
101. Gurney ME, Yamamoto H, Kwon Y (1992) Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and basic fibroblast growth factor. J Neurosci 12:3241-3247
102. Patterson PH, Nawa H (1993) Neuronal differentiation factors/cytokines and synaptic plasticity. Cell 72 (Suppl):123-137
103. Schwartz JP (1992) Neurotransmitters as neurotrophic factors: A new set of functions. Int Rev Neurobiol 34:1-23
104. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-233
105. Leon A, Dal Toso R, Presti D, Benevegnù D, Facci L, Kirschner G, Tettamanti G, Toffano G (1988) Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: II. Modulatory effects of gangliosides. J Neurosci 8:746-753
106. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neurosci 40:445-452
107. Nikkhah G, Odin P, Smits A, Tingström A, Othberg A, Brundin P, Funa K, Lindvall O (1993) Platelet derived growth factor promotes survival of rat and human mesencephalic neurons in culture. Exp Brain Res 92:516-523
108. Prochiantz A, Daguet M-C, Herbet A, Glowinski J (1981) Specific stimulation of in vitro maturation of mesencephalic dopaminergic neurones by striatal membranes. Nature 293:570-572
109. Dal Toso D, Georgi O, Soranzo C, Kirschner G, Ferrari G, Favaron M, Benevegnù D, Presti D, Vicini S, Toffano G, Azzone GF, Leon A (1988) Development and survival of neurons in dissociated mesencephalic serumfree cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF) J Neurosci 8:733-745
110. O’Malley EK, Sieber B-A, Black IB, Dreyfus CF (1992) Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture. Brain Res 582:65-70
111. Walicke PA (1988) Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J Neurosci 8:2618-2627
112. Brenneman DE, Schultzberg M, Bartfai T, Gozes I (1992) Cytokine regulation of neuronal survival. J Neurochem 38:454-460
113. Giacobini MMJ, Hoffer BJ, Zerbe G, Olson L (1991) Acidic and basic fibroblast growth factors augment growth of fetal brain tissue grafts. Exp Brain Res 86:73-81
114. Hagg T, Quon D, Higaki J, Varon S (1992) Ciliary neurotrophic factor prevents neuronal degeneration and promotes low affinity NGF receptor expression in the adult rat CNS. Neuron 8:145-148